KristinKZornMD
Obstetrics & Gynecology • Little Rock, ARGynecologic Oncology
Assistant Professor, Ob/Gyn & Reproductive Science, University of Pittsburgh School of Medicine
Dr. Zorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
# 783
Little Rock, AR 72205Phone+1 501-686-8000
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2003 - 2005
University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 1997 - 2001
University of Alabama School of MedicineClass of 1997
Certifications & Licensure
AR State Medical License 2013 - 2026
PA State Medical License 2005 - 2014
OK State Medical License 2003 - 2006
AL State Medical License Active through 2005
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Publications & Presentations
PubMed
- Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes?Kristin K Zorn, Melinda E Simonson, Jennifer L Faulkner, Cyndee L Carr, Joshua Acuna
JCO Oncology Practice. 2022-07-01 - Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018.Mahip Acharya, Kristin K Zorn, Melinda E Simonson, Milan Bimali, Gary W Moore
Hereditary Cancer in Clinical Practice. 2022-05-23 - 4 citationsRecurrent gynandroblastoma of the ovary with germline DICER1 mutation: A case report and review of the literature.Ann Marie Mercier, Kristin K. Zorn, Charles M. Quick, Laura B. Huffman
Gynecologic Oncology Reports. 2021-06-07
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
